| Name | Elosulfase alfa |
|---|
| Description | Elosulfase alfa (BMN 110) is a recombinant form of human N-acetylgalactosamine-6-sulfatase (GALNS). Elosulfase alfa is used as an enzyme replacement therapy for mucopolysaccharidosis IVA (MPS IVA), also known as Morquio A syndrome[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Sanford M, et al. Elosulfase alfa: first global approval. Drugs. 2014 Apr;74(6):713-8. |
| No Any Chemical & Physical Properties |